Reframing the High-density Lipoprotein (HDL) Hypothesis in Light of Clinical Trials of Cholesterol Ester Transfer Protein (CETP) Inhibitors

View at publisher
Authors: Michael J. Chehade, Michael J. Haas, Arshag D. Mooradian
Cited by: 1
References: 76

Fields of Study & Subjects

Diabetes Cardiovascular Risks and Lipoproteins Cholesterol and Lipid Metabolism Lipoproteins and Cardiovascular Health

Publication details

Journal / source
Drugs
Publisher
Springer Science and Business Media LLC
Volume
86
Issue
7
Pages
1091–1101
Publication date
16 May 2026
Language
EN